American Journal of Kidney Diseases
Volume 55, Issue 2 , Pages 335-343, February 2010

Tubular Toxicity in Sirolimus- and Cyclosporine-Based Transplant Immunosuppression Strategies: An Ancillary Study From a Randomized Controlled Trial

  • Stefan Franz, MD

      Affiliations

    • Clinic for Transplantation Immunology and Nephrology, University Hospital, Basel, Switzerland
    • ,
  • Axel Regeniter, MD

      Affiliations

    • Laboratory Medicine, University Hospital, Basel, Switzerland
    • ,
  • Helmut Hopfer, MD

      Affiliations

    • Institute of Clinical Pathology, University Hospital, Basel, Switzerland
    • ,
  • Michael Mihatsch, MD

      Affiliations

    • Institute of Clinical Pathology, University Hospital, Basel, Switzerland
    • ,
  • Michael Dickenmann, MD

      Affiliations

    • Clinic for Transplantation Immunology and Nephrology, University Hospital, Basel, Switzerland
    • Corresponding Author InformationAddress correspondence to Michael Dickenmann, MD, Clinic for Transplantation Immunology and Nephrology, University Hospital, Petersgraben 4, CH-4031 Basel, Switzerland

Received 8 December 2008; accepted 9 September 2009. published online 18 November 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Originally published online as doi:10.1053/j.ajkd.2009.09.004 on November 18, 2009.

 Trial registration: www.clinicaltrials.gov; study number: NCT00812123.

PII: S0272-6386(09)01187-1

doi:10.1053/j.ajkd.2009.09.004

Refers to article:

  • Why Do Patients Develop Proteinuria With Sirolimus? Do We Have the Answer?

    Jeremy R. Chapman, Gopala K. Rangan
    American Journal of Kidney Diseases February 2010 (Vol. 55, Issue 2, Pages 213-216)

American Journal of Kidney Diseases
Volume 55, Issue 2 , Pages 335-343, February 2010

Article Tools

* Image Usage & Resolution